An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase

PHASE3CompletedINTERVENTIONAL
Enrollment

281

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

January 5, 2017

Study Completion Date

July 25, 2017

Conditions
Ulcerative Colitis
Interventions
DRUG

Mesalazine Enema

DRUG

Placebo Enema

Trial Locations (1)

Unknown

The 6th hospital affiliated to Zhongshan University (there may be other sites in this country), Guangzhou

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY